Since tumour cells display enhanced proliferation relative to most normal cells, with the exception of progenitor and stem cells, targeting the replication machinery through RECQL4 seem to be a promising strategy with limited consequences for non‐cancerous cells. This evidence concerns the gene RECQL4 and neoplasm.